Leukotriene receptor antagonists in the treatment of allergic rhinitis

Annals of Pharmacotherapy

Volumn 35, Issue 10, 2001, Pages 1274-1277

  Maynard, M L ^a   Ernst, M E ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Allergic rhinitis; Leukotriene antagonists; Montelukast; Zafirlukast

Indexed keywords

LEUKOTRIENE RECEPTOR BLOCKING AGENT; MONTELUKAST; ZAFIRLUKAST;

ALLERGIC RHINITIS; CLINICAL TRIAL; DRUG EFFICACY; HUMAN; MEDICAL INFORMATION; META ANALYSIS; PRIORITY JOURNAL; REVIEW; SYMPTOMATOLOGY; TREATMENT OUTCOME;

EID: 0034791749     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1A001     Document Type: Review

References (13)

1. Diagnosis and management of rhinitis: Complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology
2. Prevalence of allergic rhinitis in the United States
3. Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: A randomized, placebo-controlled clinical trial
4. Leukotrienes in rhinitis
5. The role of leukotrienes and antileukotriene agents in the pathogenesis and treatment of allergic rhinitis
6. 4 in allergic rhinitis
7. Comparative role of peptide leukotrienes and histamine in the development of nasal mucosal swelling in nasal allergy
8. Phenylpropanolamine and the risk of hemorrhagic stroke
9. Ischemic colitis associated with pseudoephedrine: Four cases
10. 4-receptor antagonist, ICI 204,219, relieves symptoms of acute seasonal allergic rhinitis
11. Randomized placebo-controlled study comparing a leukotriene receptor antagonist and a nasal glucocorticoid in seasonal allergic rhinitis
12. Quality of life and rhinitic symptoms: Results of a nationwide survey with the SF-36 and RQLQ questionnaires